Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Review of the novelties presented at the 28th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) (II).
Changes in Methionine Metabolism and Histone H3 Trimethylation Are Linked to Mitochondrial Defects in Multiple Sclerosis.
Neuro-immune dysfunction during brain aging: new insights in microglial cell regulation.
Methotrexate is an alternative to azathioprine in neuromyelitis optica spectrum disorders with aquaporin-4 antibodies.
Cortical grey matter demyelination can be induced by elevated pro-inflammatory cytokines in the subarachnoid space of MOG-immunized rats.
Potential of Urinary Metabolites for Diagnosing Multiple Sclerosis.
Peginterferon beta-1a in multiple sclerosis: 2-year results from ADVANCE.
Kinetic Characterization of Ebselen, Chelerythrine and Apomorphine as Glutaminase Inhibitors.
Detection of JCPyV microRNA in blood and urine samples of multiple sclerosis patients under natalizumab therapy.
Low dose cyclophosphamide effectively mobilizes peripheral blood stem cells in patients with autoimmune disease.
Measuring myeloperoxidase activity in biological samples.
Regulatory effect of triiodothyronine on brain myelination and astrogliosis after cuprizone-induced demyelination in mice.
Variables Related to Working Capability among Swiss Patients with Multiple Sclerosis-A Cohort Study.
A program to facilitate retention of employment among persons with multiple sclerosis.
Anti-Inflammatory Potential of Newly Synthesized 4-[(Butylsulfinyl)methyl]-1,2-benzenediol in Lipopolysaccharide-Stimulated BV2 Microglia.
Adjusted Indirect Comparison of Oral Multiple Sclerosis Agents.
The repair Schwann cell and its function in regenerating nerves.
Human interferon regulatory factor 5 homologous epitopes of Epstein-Barr virus and Mycobacterium avium subsp. paratuberculosis induce a specific humoral and cellular immune response in multiple sclerosis patients.
Molecular mechanisms of estrogen for neuroprotection in spinal cord injury and traumatic brain injury.
High-Throughput Screening Platform for the Discovery of New Immunomodulator Molecules from Natural Product Extract Libraries.
Kinetics of IL-6 production defines T effector cell responsiveness to regulatory T cells in multiple sclerosis.
Intrathecal Baclofen in Spinal Spasticity: Frequency and Severity of Withdrawal Syndrome.
Stratified mixture modeling for segmentation of white-matter lesions in brain MR images.
Autoimmunity in multiple sclerosis need not be abnormal.
Unaltered regulatory B-cell frequency and function in patients with multiple sclerosis.
Pages
« first
‹ previous
…
545
546
547
548
549
550
551
552
553
…
next ›
last »